Abey Eapen

ORCID: 0000-0003-1951-758X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Reproductive System and Pregnancy
  • Ectopic Pregnancy Diagnosis and Management
  • Assisted Reproductive Technology and Twin Pregnancy
  • Ovarian function and disorders
  • Endometriosis Research and Treatment
  • Reproductive Biology and Fertility
  • Pregnancy and preeclampsia studies
  • Reproductive Health and Technologies
  • Prenatal Screening and Diagnostics
  • Pregnancy and Medication Impact
  • Maternal and fetal healthcare
  • Male Reproductive Health Studies
  • Uterine Myomas and Treatments
  • Vitamin D Research Studies
  • Preterm Birth and Chorioamnionitis
  • Sperm and Testicular Function
  • Organ and Tissue Transplantation Research
  • Neonatal Respiratory Health Research
  • Birth, Development, and Health
  • Gynecological conditions and treatments
  • Sexual Differentiation and Disorders
  • Pregnancy-related medical research
  • Reproductive Health and Contraception
  • Renal Transplantation Outcomes and Treatments
  • Gestational Trophoblastic Disease Studies

University of Iowa
2019-2024

University of Iowa Hospitals and Clinics
2018-2022

University of Birmingham
2015-2020

University of Iowa Health Care
2020

RELX Group (United States)
2020

Aalborg University Hospital
2020

University Hospitals Birmingham NHS Foundation Trust
2020

University of Amsterdam
2020

University of Glasgow
2020

Heartlands Hospital
2020

Bleeding in early pregnancy is strongly associated with loss. Progesterone essential for the maintenance of pregnancy. Several small trials have suggested that progesterone therapy may improve outcomes women who bleeding pregnancy.We conducted a multicenter, randomized, double-blind, placebo-controlled trial to evaluate progesterone, as compared placebo, vaginal Women were randomly assigned receive suppositories containing either 400 mg or matching placebo twice daily, from time at which...

10.1056/nejmoa1813730 article EN New England Journal of Medicine 2019-05-08

Background and objectives Progesterone is essential to maintain a healthy pregnancy. Guidance from the Royal College of Obstetricians Gynaecologists Cochrane review called for definitive trial test whether or not progesterone therapy in first trimester could reduce risk miscarriage women with history unexplained recurrent (RM). The PROMISE was conducted answer this question. A concurrent cost-effectiveness analysis conducted. Design setting randomised, double-blind, placebo-controlled,...

10.3310/hta20410 article EN publisher-specific-oa Health Technology Assessment 2016-05-01

Does administration of recombinant human granulocyte colony stimulating factor (rhG-CSF) in the first trimester improve pregnancy outcomes, among women with a history unexplained recurrent loss? rhG-CSF administered did not outcomes loss. The only previous randomized controlled study miscarriage 68 primary found statistically significant reduction and improvement live birth rates. A further four observational studies where G-CSF was used population were identified literature, two which...

10.1093/humrep/dey393 article EN cc-by-nc Human Reproduction 2019-01-21

Background Progesterone is essential for a healthy pregnancy. Several small trials have suggested that progesterone therapy may rescue pregnancy in women with early bleeding, which symptom strongly associated miscarriage. Objectives (1) To assess the effects of vaginal micronised bleeding first 12 weeks (2) evaluate cost-effectiveness bleeding. Design A multicentre, double-blind, placebo-controlled, randomised trial Setting total 48 hospitals UK. Participants Women aged 16–39 years...

10.3310/hta24330 article EN publisher-specific-oa Health Technology Assessment 2020-06-01

Vitamin D deficiency has been associated with an increased risk of abnormal pregnancy implantation leading to obstetric complications such as pre-eclampsia and fetal growth restriction. However, the effect vitamin on reproductive treatment outcomes in couples undergoing assisted is poorly understood. This study investigates association between women treatments? A prospective cohort conducted at a large tertiary teaching hospital, United Kingdom. Five hundred were recruited September 2013...

10.1186/s12978-019-0769-7 article EN cc-by Reproductive Health 2019-07-15

Abstract Problem Recurrent implantation failure (RIF) after multiple embryo transfers remains a vexing problem and immunomodulators have been used with conflicting results. This study aims to assess the effect of immunomodulation therapy on live birth rate (LBR) in women RIF undergoing assisted reproduction treatment (ART). Method design is retrospective cohort multicentre network private conception units UK. The included who had at least two failed attempts CARE fertility period from 1997...

10.1111/aji.13819 article EN American Journal of Reproductive Immunology 2024-02-01

Objective: To evaluate the dose-dependent effect of propofol in hemodynamic parameters and reproductive outcomes following In-Vitro Fertilization (IVF) oocyte retrieval (OR)Design: Retrospective cohort studySubjects: 1575 women who underwent their first OR under monitored anesthesia care (MAC) subsequent fresh embryo transfer (ET) between January 2016 through December 2022Exposure: Women study were categorized into five cohorts (cohorts A – E) based on increasing dose total μg/kg/min.Main...

10.17077/2154-4751.34426 article EN Proceedings in Obstetrics and Gynecology 2025-05-29

Objectives To assess the cost‐effectiveness of progesterone compared with placebo in preventing pregnancy loss women early vaginal bleeding. Design Economic evaluation alongside a large multi‐centre randomised placebo‐controlled trial. Setting Forty‐eight UK NHS units. Population Four thousand one hundred and fifty‐three aged 16–39 years bleeding ultrasound evidence an intrauterine sac. Methods An incremental analysis was performed from National Health Service (NHS) Personal Social Services...

10.1111/1471-0528.16068 article EN cc-by BJOG An International Journal of Obstetrics & Gynaecology 2020-01-30

(Abstracted from Am J Obstet Gynecol 2020;223(2):167–176) Historically, a lack of methodologically strong and generalizable studies has limited policy makers recommending the use progesterone supplementation to improve outcomes in women at high risk miscarriage. The PROMISE PRISM trials were carried out rectify this generate robust evidence on role prevent

10.1097/ogx.0000000000000877 article EN Obstetrical & Gynecological Survey 2020-12-01

Abstract Study question What is the relative effectiveness and safety of existing COS protocols for women undergoing assisted reproductive technology (ART) treatment? Summary answer There was no difference in live birth between all protocols, but short antagonist may reduce ovarian hyperstimulation syndrome with predicted normal/high response. known already Controlled stimulation an essential step most ART cycles. It involves administration exogenous gonadotrophins to induce multifollicular...

10.1093/humrep/deac104.009 article EN Human Reproduction 2022-06-29

Purpose of this retrospective study was to investigate if serum markers, men's age, interval since vasectomy, BMI, testicular size and smoking could predict the success epididymal or sperm aspiration (PESA/TESA) in vasectomized men. Forty-four consecutively performed PESA/TESA procedures were reviewed retrospectively. Motile retrieved from 77.3% procedures. Mean Inhibin-B (Inh-B) level tended be higher men who had motile compared those not (180.3 versus 126.2 pg/ml, p = 0.05). Univariate...

10.1080/14647273.2016.1191681 article EN Human Fertility 2016-04-02

( N Engl J Med . 2019;380(19):1815–1824) This study aimed to determine whether the controversial use of progesterone therapy in women with early bleeding pregnancy could result a higher incidence live births than placebo. It was multicenter, randomized, double-blind, placebo-controlled trial evaluate progesterone, as compared placebo, vaginal pregnancy. Women received suppositories or from presentation 16 weeks if helps improve outcomes for

10.1097/01.aoa.0000603772.96889.98 article EN Obstetric Anesthesia Digest 2019-11-25
Coming Soon ...